The combination of Letrozole and trastuzumab as first line or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

収録刊行物

• Breast Cancer Res Treat

  Breast Cancer Res Treat 102 43-49, 2007